Functions of Fukutin, a Gene Responsible for Fukuyama Type Congenital Muscular Dystrophy, in Neuromuscular System and Other Somatic Organs

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|10|2|169-179

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.10, Iss.2, 2010-06, pp. : 169-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapies for muscular dystrophy and other muscle wasting conditions

By Lynch G.S.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 587-601

Informa Healthcare

Access to resources Recommend Favorite

Short GCG expansions in the PAB II gene for oculopharyngeal muscular dystrophy and diagnostic thereof

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 11, 1999-11 ,pp. : 1579-1581

Informa Healthcare

Access to resources Recommend Favorite

Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy

By ’t Hoen Peter AC   van der Wees Caroline GC   Aartsma-Rus Annemieke   Turk Rolf   Goyenvalle Aurélie   Danos Olivier   Garcia Luis   van Ommen Gert-Jan B   den Dunnen Johan T   van Deutekom Judith CT  

Pharmacogenomics, Vol. 7, Iss. 3, 2006-04 ,pp. : 281-297

Future Medicine

Access to resources Recommend Favorite

Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors

By  

Current Gene Therapy, Vol. 12, Iss. 3, 2012-06 ,pp. : 139-151

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite